Product
I-131-CLR1404
Aliases
131I-CLR1404, 18-(p-[I-131]-iodophenyl)octadecyl phosphocholine, CLR 131
1 clinical trial
1 indication
Indication
Multiple MyelomaClinical trial
Phase 1, Open-Label, Dose Escalation Study of I-131-CLR1404 in Patients With Relapsed or Refractory Multiple MyelomaStatus: Completed, Estimated PCD: 2020-12-09